RESUMEN
BACKGROUND: The rapidly improving tools of genetic engineering may make it possible to overcome the humoral immune barrier that prevents xenotransplantation. We hypothesize that levels of human antibody binding to donor tissues from swine must approximate the antibody binding occurring in allotransplantation. It is uncertain if this is an attainable goal. Here we perform an initial analysis of this issue by comparing human antibody binding to red blood cells (RBC) isolated from knockout swine and to allogeneic or autologous human RBC. METHODS: Human sera were incubated with RBC isolated from various genetically engineered swine or from humans. The level of IgG and IgM binding to these cells were compared using either flow cytometry or a novel mass spectrometric assay. RESULTS: Mass spectroscopic quantitation of human antibody binding demonstrated that as few as 3 gene inactivations can reduce the levels human antibody binding to swine RBC that is as low as autologous human RBC. Flow cytometry showed that RBC from 2-gene knockout swine exhibited less human antibody binding than human blood group O allogeneic RBC in 22% of tested sera. Deletion of a third gene from pigs resulted in 30% of human samples having less IgG and IgM RBC xenoreactivity than alloreactivity. CONCLUSIONS: Xenoantigenicity of swine RBC can be eliminated via gene disruption. These results suggest that the gene knockout approach may be able reduce antigenicity in other pig tissues to levels that enable the xenotransplantation humoral barrier to be overcome.
Asunto(s)
Antígenos Heterófilos/genética , Antígenos Heterófilos/inmunología , Eritrocitos/inmunología , Técnicas de Inactivación de Genes , Histocompatibilidad , Porcinos/inmunología , Animales , Animales Modificados Genéticamente , Antígenos Heterófilos/sangre , Sitios de Unión de Anticuerpos , Citometría de Flujo , Supervivencia de Injerto , Humanos , Inmunidad Humoral , Isoanticuerpos/sangre , Isoanticuerpos/inmunología , Unión Proteica , Porcinos/sangre , Porcinos/genética , Espectrometría de Masas en Tándem , Tolerancia al Trasplante , Trasplante HeterólogoRESUMEN
BACKGROUND AND OBJECTIVE: The absence of α-gal in humans is caused by the inactivity of α-1,3GT gene. However, humans have pre-existing and abundant anti-gal antibodies. Xenotransplantation procedures have indicated the high potential of introducing α-1,3GT gene to synthesize α-gal for cancer gene therapy by mimicking hyper-acute rejection. The aim of this study is to construct a lung cancer A549 cell line that expressed α-gal, and to observe the antitumor mechanisms mediated by human serum. METHODS: A549 cells were transfected with pEGFP-N1-GT plasmids constructed in a previous study. A stable transgenic cell line, A549-GT, was then selected and cultivated. The biological characteristics of A549-GT cells, including morphology and proliferation, were examined. α-1,3GT mRNA expression was detected by RT-PCR. Direct immunofluorescence staining and flow cytometry (FCM) were used to analyze the synthesis of α-gal in A549-GT. The binding of human serum IgM and C3 with A549-GT were also detected. RESULTS: α-1,3GT mRNA was expressed in A549-GT. Direct immunofluorescence staining and FCM indicated a high and stable α-gal expression rate in A549-GT. Compared with parental A549 cells, the biological characteristics of A549-GT were unaltered. α-Gal expression was not detected in the human fetal lung fibroblast cell line MRC-5 even though A549-GT and its culture medium were cultivated with the enzyme. Immunofluorescence staining and FCM also indicated abundant binding between A549-GT treated with human serum and IgM/C3. CONCLUSIONS: α-Gal expression in tumor cells by gene transduction can induce complement-dependent cytototic antitumor effects.
Asunto(s)
Antígenos Heterófilos/sangre , Antígenos Heterófilos/inmunología , Galactosa/sangre , Galactosa/inmunología , Neoplasias Pulmonares/patología , Animales , Antígenos Heterófilos/genética , Muerte Celular/inmunología , Línea Celular Tumoral , Complemento C3/inmunología , Epítopos/inmunología , Galactosa/genética , Galactosiltransferasas/genética , Regulación Neoplásica de la Expresión Génica/inmunología , Humanos , Inmunoglobulina M/sangre , ARN Mensajero/genética , ARN Mensajero/metabolismoRESUMEN
In steroid enzyme immunoassay (EIA), homologous and heterologous combinations of enzyme conjugate with immunogen influences labeled steroid recognition by antibodies that affect sensitivity of the assay. To develop testosterone enzyme linked immunosorbent assay (ELISA), antibodies were generated against testosterone-3-carboxymethyloxime-bovine serum albumin (T-3-CMO-BSA), testosterone-11-hemisuccinate-bovine serum albumin (T-11-HS-BSA), testosterone-17-hemisuccinate-bovine serum albumin (T-17-HS-BSA), testosterone-17-glucuronide-bovine serum albumin (T-17-G-BSA), and testosterone-19-carboxymethylether-bovine serum albumin (T-19-CME-BSA). Testosterone horseradish peroxidase (HRP) enzyme conjugate were prepared using carboxyl derivatives of 11-keto-testosterone (11-keto-T) and 1-dehydrotestosterone (1-Dehydro-T). Ten combinations of heterologous assays were evaluated. The data of the present study revealed that the use of the T-11-HS-BSA antibody in antigen plus site heterologous assay that employed 11-keto-testosterone-3-CMO-HRP as the label showed binding and displacement, and led to the development of sensitive and specific assay.
Asunto(s)
Antígenos Heterófilos/sangre , Ensayo de Inmunoadsorción Enzimática/métodos , Testosterona/sangre , Adolescente , Adulto , Animales , Anticuerpos Heterófilos/inmunología , Antígenos Heterófilos/inmunología , Femenino , Peroxidasa de Rábano Silvestre/química , Humanos , Masculino , Conejos , Albúmina Sérica Bovina/inmunología , Testosterona/análogos & derivados , Testosterona/inmunología , Adulto JovenRESUMEN
There is increasing interest in biologics, i.e. human-originated biological pharmaceutics. Most of the protein drugs developed so far, such as immunoglobulins and erythropoietin, are secreted glycoproteins; as a result, any non-human-type glycans, such as αGal and NeuGc, derived from animal cells and sera must be removed to circumvent undesirable immunogenic reactions. In this study, we made an extensive search for potential xenoantigenic glycans among a panel of mammalian sera. As a result, sera belonging to the order Artiodactyla, i.e. bovine, lamb and goat sera, were found to contain substantial amounts of hypersialylated biantennary glycans closely associated with a type-I lactosamine structure containing a unique tetrasaccharide, Siaα2-3Galß1-3(Siaα2-6)GlcNAc. In all three Artiodactyla sera, the most abundant structure was Siaα2-3Galß1-3(Siaα2-6)GlcNAcß1-2Manα1-3[Siaα2-6Galß1-4GlcNAcß1-2Manα1-6]Manß1-4GlcNAcß1-4GlcNAc. A dually hypersialylated biantennary structure, Siaα2-3Galß1-3(Siaα2-6)GlcNAcß1-2Manα1-3[Siaα2-3Galß1-3(Siaα2-6)GlcNAcß1-2Manα1-6]Manß1-4GlcNAcß1-4GlcNAc, was also abundant (10%) in bovine serum. The amount of hypersialylated glycans among total sialylated glycans was 46, 26 and 23% in bovine, lamb and goat sera, respectively. On the other hand, such structures could not be detected in the sera of other animals including human. The biological functions and the immunogenicity of the hypersialylated glycans in these animals remain to be elucidated; however, it is worth noting that glycoproteins biosynthesized from Artiodactyla cells and those contaminated with bovine serum might enhance undesirable antigenicity in human patients.
Asunto(s)
Amino Azúcares/química , Antígenos Heterófilos/sangre , Antígenos Heterófilos/inmunología , Artiodáctilos/metabolismo , Glicoproteínas/metabolismo , Polisacáridos/sangre , Polisacáridos/inmunología , Ácidos Siálicos/metabolismo , Animales , Antígenos Heterófilos/aislamiento & purificación , Bovinos , Cabras , Caballos , Humanos , Polisacáridos/aislamiento & purificación , Ovinos , PorcinosRESUMEN
Interacting with erythrocytes which transport immune complexes and xenogenic antigens myelocariocytes and leukocytes of circulating blood produce from them erythroclasic clusters in bone marrow and autorosettes in circulating blood. Formation of these cellular associations is completed with exocytic lysis of included in them erythrocytes by myelocariocytes and leukocytes. It is supposed that the lysis of erythrocytes within erythroclasic clusters and autorosettes is the final stage of erythrocytic clearance of immune complexes and xenogenic antigens.
Asunto(s)
Complejo Antígeno-Anticuerpo/sangre , Antígenos Heterófilos/sangre , Células de la Médula Ósea/inmunología , Agregación Eritrocitaria/inmunología , Eritrocitos/inmunología , Leucocitos/inmunología , Anemia Aplásica/sangre , Anemia Aplásica/inmunología , Anemia Aplásica/patología , Complejo Antígeno-Anticuerpo/inmunología , Antígenos Heterófilos/inmunología , Células de la Médula Ósea/patología , Niño , Eritrocitos/patología , Hemólisis/inmunología , Humanos , Leucocitos/patología , Macrófagos/inmunología , Macrófagos/patología , Leucemia-Linfoma Linfoblástico de Células Precursoras/sangre , Leucemia-Linfoma Linfoblástico de Células Precursoras/inmunología , Leucemia-Linfoma Linfoblástico de Células Precursoras/patología , Púrpura Trombocitopénica Idiopática/sangre , Púrpura Trombocitopénica Idiopática/inmunología , Púrpura Trombocitopénica Idiopática/patologíaRESUMEN
The ability to genetically engineer pigs that no longer express the Galalpha1,3Gal (Gal) oligosaccharide has been a significant step toward the clinical applicability of xenotransplantation. Using a chronic immunosuppressive regimen based on costimulatory blockade, hearts from these pigs have survived from 2 to 6 months in baboons. Graft failure was predominantly from the development of a thrombotic microangiopathy. Potential contributing factors include the presence of preformed anti-nonGal antibodies or the development of low levels of elicited antibodies to nonGal antigens, natural killer (NK) cell or macrophage activity, and inherent coagulation dysregulation between pigs and primates. The breeding of pigs transgenic for an "anticoagulant" gene, such as human tissue factor pathway inhibitor, hirudin, or CD39, or lacking the gene for the prothrombinase, fibrinogen-like protein-2, is anticipated to inhibit the change in the endothelium to a procoagulant state that takes place in the pig organ after transplantation. The identification of the targets for anti-nonGal antibodies and/or human macrophages might allow further genetic modification of the pig, and xenogeneic NK cell recognition and activation may be inhibited by the transgenic expression of human leukocyte antigen molecules and/or by blocking the function of activating NK receptors. The ultimate goal of induction of T-cell tolerance may be possible only if these hurdles in the coagulation system and innate immunity can be overcome.
Asunto(s)
Animales Modificados Genéticamente , Galactosiltransferasas/genética , Trasplante de Órganos , Porcinos/genética , Trasplante Heterólogo , Animales , Anticuerpos Heterófilos/inmunología , Antígenos Heterófilos/sangre , Antígenos Heterófilos/inmunología , Coagulación Sanguínea , Humanos , Terapia de Inmunosupresión , Trasplante de Órganos/efectos adversos , Trasplante de Órganos/tendencias , Primates/inmunología , Primates/cirugía , Porcinos/inmunología , Trombosis/etiología , Trombosis/prevención & control , Tolerancia al Trasplante , Trasplante Heterólogo/efectos adversos , Trasplante Heterólogo/inmunología , Trasplante Heterólogo/tendenciasRESUMEN
The purpose of the present investigation was to generate pregnancy associated glycoprotein (PAG)-profiles throughout pregnancy in a heterogenous sample of sheep using a radioimmunoassay with a heterologous antibody (anti-caPAG(55+59), #708) and utilize them for the purpose of pregnancy detection. From 2 weeks after the introduction of males into the breeding herd until 4 weeks after parturition, weekly blood samples were collected from 66 pregnant and 25 non-pregnant ewes of various breeds. Between 3 and 5 weeks after conception, plasma PAG levels increased, remained almost stable until week 17, then continued to increase, culminating in a drastic surge during the last 2 weeks of pregnancy. By 4 weeks of gestation, the plasma PAG level exceeded the level typical for non-pregnant ewes by five standard deviations, permitting a reliable pregnancy diagnosis. Plasma PAG levels were higher in twin-bearing ewes than in ewes carrying a single lamb, differences getting more evident as pregnancy proceeded. Neither breed and parity of the mother nor sex and weight of lambs borne exerted a significant effect. The heterologous assay system utilizing a caprine antibody proved to deliver results that are more consistent and less depending on various variables than those used in other studies. It may be concluded that, at the present state of development, the assay provides a reliable means of diagnosing pregnancy in sheep from the 4th week after they have been bred onward.
Asunto(s)
Proteínas Gestacionales/análisis , Pruebas de Embarazo/veterinaria , Preñez , Radioinmunoensayo/métodos , Ovinos , Animales , Antígenos Heterófilos/análisis , Antígenos Heterófilos/sangre , Femenino , Edad Gestacional , Glicoproteínas/análisis , Glicoproteínas/sangre , Tamaño de la Camada , Embarazo , Proteínas Gestacionales/sangre , Embarazo Múltiple/sangre , Ovinos/sangre , Ovinos/fisiologíaRESUMEN
Pigs are considered the most likely source of organs and tissues should the barriers to xenotransplantation be overcome. The use of animal blood for transfusion, xenotransfusion, would have advantages over blood from random human donors with respect to supply and infection control. Large animals such as cows would be more suitable than pigs for blood donation because of easier venous access and large volume phlebotomy. Blood from 12 Holstein cows was typed and then tested for hemagglutination assay (HA), complement mediated lysis (CML), human IgM and IgG antibody binding, anti-human globulin augmented clinical cross-match and osmotic fragility with normal human serum. Results were compared with porcine erythrocytes (pRBC) and with human type O controls (hRBC). The frequency of ultra-low xenoantigen expressors was tested in a larger herd of various breeds using HA and CML. Median HA and CML titers were one of six (no HA-one of 64) and one of 26 (no CML-one of 64), respectively for bovine erythrocytes (bRBC). Hemagglutination titer was significantly higher for pRBC at one of 170 (one of four-one of 1024). HA and CML were lowest with bovine blood group J. Repeated HA and CML were negative with bRBC from one cow that also tested negative by anti-human globulin augmented cross-match with seven of nine random human sera representing the different blood groups. However, flow cytometry showed that bRBC from all cows bound human IgM and IgG. IgM mean channel fluorescence (MCF) was positively correlated with HA titer. The mean corpuscular fragility of pRBC, bRBC, and hRBC was 0.56, 0.48 and 0.41%, respectively. The frequency of HA-negative and CML-negative cows were 20 and 35%, respectively in herds of 49 animals. Bovine RBC elicit variable in vitro responses from human serum but these are uniformly much less than those seen with pRBC. Bovine RBC is more robust than pRBC. These characteristics including the potential ease and volume of blood collection make the cow a more suitable blood donor than the pig.
Asunto(s)
Bovinos/sangre , Transfusión de Eritrocitos , Sistema del Grupo Sanguíneo ABO , Animales , Antígenos Heterófilos/sangre , Ensayo de Actividad Hemolítica de Complemento , Proteínas del Sistema Complemento/inmunología , Eritrocitos/fisiología , Estudios de Factibilidad , Femenino , Pruebas de Hemaglutinación , Humanos , Porcinos/sangreRESUMEN
Adenoviral transfer of human apo A-I in Balb/c mice induces a strong humoral immune response against the transgene product when expression is driven from the ubiquitously active CMV promoter but induces no immune response when driven by the hepatocyte-specific 256-base pair apo A-I promoter. Here the hypothesis was tested, which is that the humoral immune response against the circulating transgene product correlates with its expression in antigen-presenting cells. No humoral immune response was observed after adenoviral transfer of vectors with human apo A-I expression driven by the hepatocyte-specific apo C-II or 1.5-kilobase (kb) human alpha(1)-antitrypsin promoter, but antibodies were induced after transfer with vectors driven by the ubiquitously active U1b promoter and the murine MHCII E beta promoter. A strict correlation was observed between antigen expression in the spleen and the occurrence of an immune response. Coinjection of the 1.5-kb human alpha(1)-antitrypsin and the murine MHCII E beta promoter-driven vectors resulted in a very short-lived humoral immune response against human apo A-I, suggesting that the time course of human apo A-I expression is a critical determinant of the development of tolerance for human apo A-I. High titers of antibodies against human apo A-I after subcutaneous gene transfer with the MHCII E beta promoter-driven vector underscore the potential of this promoter for vaccination purposes. In conclusion, humoral immune response in mice against a circulating antigen induced by adenoviral transfer is strictly dependent on expression in antigen-presenting cells.
Asunto(s)
Formación de Anticuerpos , Células Presentadoras de Antígenos/metabolismo , Antígenos Heterófilos/inmunología , Apolipoproteína A-I/inmunología , Técnicas de Transferencia de Gen/normas , Adenoviridae/genética , Animales , Anticuerpos Heterófilos/sangre , Células Presentadoras de Antígenos/inmunología , Antígenos Heterófilos/sangre , Antígenos Heterófilos/genética , Apolipoproteína A-I/sangre , Apolipoproteína A-I/genética , Vectores Genéticos , Humanos , Tolerancia Inmunológica , Ratones , Ratones Endogámicos BALB C , Ratones Transgénicos , Regiones Promotoras Genéticas , ARN Mensajero/análisis , Bazo/citología , Bazo/inmunología , Bazo/metabolismoRESUMEN
Intracerebral neural xenografts elicit a host immune response that results in their rapid rejection. This forms a key barrier to the therapeutic use of xenogeneic tissue transplantation for conditions such as Parkinson's disease. The current study sought to provide insight into the cellular components of donor cell suspensions that are important in stimulating the host rejection response and thereby to suggest rational manipulations of xenogeneic donor tissue that might ultimately enhance its clinical utility. The neural stem cell mitogens, epidermal growth factor and fibroblast growth factor-2, have been used to isolate and expand populations of primordial neural precursor cells from the embryonic pig brain. The immune response elicited by these cells on transplantation into the non-immunosuppressed rat has been fully characterised. In the first experiments, expanded neural precursors were grafted into the hemi-parkinsonian, non-immunosuppressed Sprague-Dawley rat and graft status and host response examined 10, 21, 35 and 60 days post-transplantation. While equivalent primary tissue grafts were completely eliminated at 35 days, grafts of expanded neural precursors with healthy neurofilament-positive projections were present at all time-points, and two large grafts remained even at 60 days. Some grafts appeared to elicit minimal host immune responses at the time-points they were examined, although most did appear to be undergoing a rejection process since a co-ordinated response involving host cytotoxic T-lymphocytes, microglia/macrophages, immunoglobulin M and complement could be demonstrated to varying degrees. Subsequent experiments went on to demonstrate further that expanded precursor populations and primary tissue suspensions differed in their immunogenic profile. Firstly, when primary tissue was injected intraperitoneally into immunocompetent rats a vigorous primary humoral response was generated. No such response was detected following injection of expanded neural precursors. Secondly, flow cytometric analysis revealed small but significant levels of class II porcine major histocompatibility complex expression in primary cell suspensions but no such expression in expanded precursor populations.The results of this study therefore demonstrate that the immunogenicity of porcine neural cell suspensions used for intracerebral grafting is reduced when neural stem cell mitogens are used to expand precursor cells. The implications of these findings in the development of novel xenogeneic cellular therapies for neurodegenerative conditions such as Parkinson's disease are discussed.
Asunto(s)
Trasplante de Tejido Encefálico/efectos adversos , Rechazo de Injerto/inmunología , Inmunocompetencia/inmunología , Neostriado/cirugía , Trastornos Parkinsonianos/cirugía , Trasplante de Células Madre , Trasplante Heterólogo/efectos adversos , Animales , Anticuerpos/sangre , Anticuerpos/inmunología , Antígenos Heterófilos/sangre , Antígenos Heterófilos/inmunología , Biomarcadores/sangre , Trasplante de Tejido Encefálico/métodos , División Celular/efectos de los fármacos , División Celular/inmunología , Corteza Cerebral/citología , Corteza Cerebral/inmunología , Corteza Cerebral/trasplante , Femenino , Feto , Citometría de Flujo , Rechazo de Injerto/metabolismo , Rechazo de Injerto/fisiopatología , Supervivencia de Injerto/inmunología , Mitógenos/farmacología , Neostriado/inmunología , Neostriado/fisiopatología , Neuronas/citología , Neuronas/inmunología , Neuronas/trasplante , Trastornos Parkinsonianos/metabolismo , Trastornos Parkinsonianos/fisiopatología , Ratas , Ratas Sprague-Dawley , Células Madre/citología , Células Madre/inmunología , Porcinos , Trasplante Heterólogo/métodosRESUMEN
Advances in the field of xenotransplantation raise the intriguing possibility of using porcine red blood cells (pRBCs) as an alternative source for blood transfusion. The domestic pig is considered the most likely donor species for xenotransplantation. However, identification of xenoantigens on porcine erythrocytes and elucidation of their possible roles in antibody-mediated RBC destruction are necessary for developing clinical strategies to circumvent immunological incompatibility between humans and pigs. Although the alphaGal epitope (Galalpha1,3Galbeta1,4GIcNAc-R) is the major xenoantigen on porcine erythrocytes and is responsible for the binding of the majority of human natural antibodies, other non-alphaGal xenoantigens have been identified. The importance of these non-alphaGal xenoantigens in binding human natural antibodies and subsequently triggering immunological responses cannot be underestimated. Our data suggest that non-alphaGal xenoantigen(s) identified on the porcine erythrocyte membrane are not only recognized by xenoreactive human natural antibodies but are also involved in complement-mediated hemolysis.
Asunto(s)
Eritrocitos/inmunología , Porcinos/sangre , Animales , Anticuerpos Heterófilos/sangre , Antígenos Heterófilos/sangre , Transfusión de Eritrocitos/métodos , Humanos , Porcinos/inmunología , Trasplante Heterólogo/inmunología , Trasplante Heterólogo/métodosRESUMEN
It was noted that many sera of patients with renal allograft produce distinct precipitation lines in gel diffusion tests with about 20% of infectious mononucleosis sera. The antibodies in infectious mononucleosis sera were of IgM isotope, but, interestingly, they could be removed by guinea pig kidney homogenate, which indicated that the reactions studied were of the Hanganutziu-Deicher rather than of the Paul-Bunnell type. This contention was strengthened by the fact that positive transplantation sera reacted also with standard serum with Hanganutziu-Deicher antibodies. Thus far, the presence of the antigen in the transplantation sera could not be related to the clinical status of the patients, however, the antigen was noted primarily in those sera that did not contain heterophile transplantation antibodies. It was proposed that the antigen detected in the transplantation sera was an altered tissue antigen released from the grafted organ. Besides, interactions between two serum samples from the same patient were noted in immunodiffusion tests. These reactions occurred very seldom and were unrelated to heterophile transplantation antigens or antibodies.
Asunto(s)
Antígenos Heterófilos/sangre , Antígenos Virales/sangre , Trasplante de Riñón/inmunología , Animales , Anticuerpos Heterófilos/efectos de los fármacos , Bovinos , Epítopos , Glomerulonefritis/inmunología , Glomerulonefritis/cirugía , Rechazo de Injerto/inmunología , Cobayas , Humanos , Mononucleosis Infecciosa/sangre , Mononucleosis Infecciosa/inmunología , Masculino , Mercaptoetanol/farmacología , Persona de Mediana EdadRESUMEN
Fourteen cases of lymphoid and myeloid acute leukemia (AL) were studied for expression on blast cells of CD7 antigen, a cell surface marker found early during T lineage differentiation. This heterogenic group of CD7+ CD4-CD8- AL includes distinct cytological subvariants with: myeloid (AML MO, M1, M4, M5) and lymphoid (pre-T-cell) commitment, biphenotypic or mixed lineage AL and AL with minimal signs of blast cell differentiation, which appear not to follow lineage restriction. The latter subset of AL may represent the transformed counterpart of an early stem cell prior to lineage commitment.
Asunto(s)
Antígenos CD/sangre , Antígenos Heterófilos/sangre , Leucemia/inmunología , Enfermedad Aguda , Adulto , Niño , Humanos , InmunofenotipificaciónRESUMEN
Hyperacute rejection of vascularized porcine to primate xenografts is initiated by the binding of xenoreactive natural antibodies to donor endothelium. We tested the hypothesis that the level of xenoantigen expression varies in the population of potential porcine donors and may determine the amount of binding of xenoreactive natural antibodies to a porcine organ perfused by xenogeneic blood. Two hundred ninety pigs were studied using an inhibition ELISA that quantitated the xenoantigen level on porcine platelets. Based on this assay, the levels of xenoantigen expression in the population adhered to a normal distribution. Kidneys from pigs found to express high antigen levels and kidneys from pigs found to express low antigen levels were perfused with baboon blood using an extracorporeal circuit. In multiple experiments, a significant difference was observed in the amount of xenoreactive natural antibody adsorbed by high antigen versus low antigen organs. Normalizing for the weight of the perfused organs and for levels of natural antibody in individual baboons, high antigen organs adsorbed 3.6 +/- 1.3 U of xenoreactive natural antibody/g and low antigen organs adsorbed -0.8 +/- 1.0 U of xenoreactive natural antibody/g (P < 0.002). Immunopathology of tissues from the perfused organs demonstrated more deposition of IgM and C4 in high than in low xenoantigen organs. The quantitative relationship between binding of xenoreactive natural antibodies to platelets and to whole organs suggests that platelets are a valid representation of endothelial cell antigen expression in vivo. Despite the probable importance of Gal alpha(1-3)Gal as an epitope recognized by xenoreactive natural antibodies, differences in the binding to platelets or to organs of the GS-I-B4 lectin that recognizes that sugar had no correlation with the differences in binding of IgM to these tissues. Variation in expression of xenoantigen may be exploited to selectively breed donors for xenotransplantation that are less susceptible to attack by xenoreactive natural antibodies.
Asunto(s)
Antígenos Heterófilos/sangre , Plaquetas/inmunología , Animales , Células Cultivadas , Endotelio/citología , Endotelio/inmunología , Ensayo de Inmunoadsorción Enzimática/métodos , Citometría de Flujo , Técnica del Anticuerpo Fluorescente , Expresión Génica , PorcinosRESUMEN
A human Hanganutziu-Deicher (HD) antibody and a chicken anti-N-glycolyneuroaminyllactosylceramide (HD3) antibody were compared in their reaction against HD antigen-active ganglioside (HD3) and a glycoprotein (GP) by radioimmunoassay (RIA). The human antibody had a 50 times higher reactivity with the glycoprotein, while the chicken antibody reacted equally with both antigens. Both antibodies had a higher reactivities with HD antigen(s) in sera of five of eight lung cancer patients than 54 normal human sera. Since four of the above five sera had no abnormal titers to GP, it was concluded that their immunological status was antigen excess. The chicken antibody may be useful in follow-up studies of cancer patients to correlate the expression of HD antigen in tissues and sera with the elevation of HD antibodies, offering alternative methods of clinical prognosis of tumor growth and/or metastases. The human HD antibody may also be useful for the detection of HD antigens of glycoprotein nature.
Asunto(s)
Anticuerpos Heterófilos/inmunología , Antígenos Heterófilos/sangre , Neoplasias/inmunología , Animales , Secuencia de Carbohidratos , Pollos , Glicoproteínas/inmunología , Humanos , Datos de Secuencia Molecular , RadioinmunoensayoAsunto(s)
Antígenos Heterófilos/sangre , Plaquetas/metabolismo , Glicoproteínas de Membrana Plaquetaria/biosíntesis , Animales , Antígenos Heterófilos/análisis , Antígenos Heterófilos/biosíntesis , Western Blotting , Ensayo de Inmunoadsorción Enzimática , Humanos , Glicoproteínas de Membrana Plaquetaria/análisis , Especificidad de la Especie , PorcinosRESUMEN
Two chicken monoclonal antibodies (MAbs), HU/Ch2-7 and HU/Ch6-1, detecting Hanganutziu-Deicher (HD) antigens with N-glycolylneuraminic acid (NeuGc) at a terminal carbohydrate were reactive with bovine, sheep and horse erythrocytes examined by flowcytometry (FCM). The FCM profiles of the three animal erythrocytes treated with trypsin were different from those of non-treated cells and from each other depending on MAbs used. To identify the nature of antigenic molecules, recognized by HU/Ch2-7 and HU/Ch6-1 MAbs, solubilized erythrocytes from the above three animals were analyzed by a Western blotting method. The MAb HU/Ch2-7 identified HD antigen-specific glycoprotein in each of animal erythrocytes. These results indicate that the MAb HU/Ch2-7 is a valuable reagent for the detection of NeuGc-containing gangliosides and glycoproteins.